Compare StocksBAC vs WST

Bank of America Corporation (BAC) vs West Pharmaceutical Services, Inc. (WST): Which Is the Better Buy in 2026?

As of 2026-09-17, BAC is undervalued at $58, with a DCF intrinsic value of $142 and a margin of safety of 59%. WST is overvalued at $367, with an intrinsic value of $187 and a margin of safety of -96%. Of the two, BAC has the wider margin of safety.

BAC
Bank of America Corporation
$57.70
VS
WST
West Pharmaceutical Services, Inc.
$366.56

Rewards

BAC
  • Bank of America Corporation scores 100/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • PEG ratio of 0.90 suggests the stock is undervalued relative to its growth rate — paying less than 1x for each unit of earnings growth.
WST
  • West Pharmaceutical Services, Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Altman Z-Score of 13.89 indicates very low bankruptcy risk — the company is firmly in the safe zone.
  • Net debt/EBITDA of -0.1x means the company holds more cash than debt — a net cash position.

Risks

BAC
  • Gross margin of 0.0% is low, suggesting a competitive or commodity-like market with limited pricing power.
  • Altman Z-Score of 0.22 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
WST
  • FCF yield of 1.8% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • PEG ratio of 2.77 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Insiders have sold $5.4M worth of stock in the past 3 months — significant insider liquidation.

Key Valuation Metrics

Learn more →
BAC
WST
Valuation
N/A
Free Cash Flow
$468.90M
N/A
FCF Yield
1.82%
13.32
Trailing P/E
46.88
10.90
Forward P/E
36.74
Quality & Moat
4.37%
ROIC
17.86%
11.20%
ROE
19.09%
0.00%
Gross Margin
36.79%
0.90
PEG Ratio
2.77
Balance Sheet Safety
N/A
Net Debt / Equity
Net cash
N/A
Interest Coverage
N/A
N/A
Net Debt / EBITDA
-0.13
2.21%
Dividend Yield
0.24%
BAC: 4Ties: 1WST: 3
BACWST

Historical Fundamentals

Learn more →
BAC

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

WST

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
BAC
$2.37
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$55.63B
Δ Market Cap
+$131.83B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
WST
$1.70
created per $1 retained over 3 years
Value Creator
Σ Retained
$1.40B
Δ Market Cap
+$2.38B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
BAC
59.4% Margin of Safety
Price is 59.4% below estimated fair value
Current Price: $57.70
Fair Value: $142.10
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
WST
95.6% Overvalued
Price is 95.6% above estimated fair value
Current Price: $366.56
Fair Value: $187.43
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
BAC

Requires positive FCF to compute implied growth rate.

WST

What growth rate is the market pricing in at $367?

+20.8%
Market-Implied Owner Earnings Growth
Standard FCF implies +21.5%

The market implies +20.8% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +21.5%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
BAC
100/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by revenue predictability. Reinvestment Efficiency is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
WST
68/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with revenue predictability as the key competitive advantage. Improving margin stability would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
BAC
-2.31
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
WST
-2.77
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
BAC
Insiders 7.0%Institutions 71.3%Retail & Other 21.7%
No. of Institutional Holders4,542
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
WST
Insiders 0.7%Institutions 102.0%
No. of Institutional Holders1,211
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
BAC
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
WST
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
BAC
0
Sells (3M)
5
Sells (12M)
Total value (12M): $20.17M
MENSAH BERNARD AMPONSAH
Officer
$4.41M
@ $46.94 · 2026-03-12
BRONSTEIN SHERI B
Officer
$2.99M
@ $49.91 · 2026-03-05
SCRIVENER THOMAS M
Officer
$2.49M
@ $49.82 · 2026-03-05
ATHANASIA DEAN C
President
$6.86M
@ $50.21 · 2026-03-03
BORTHWICK ALASTAIR M.
Chief Financial Officer
$3.42M
@ $50.24 · 2026-02-27
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
WST
2
Sells (3M)
4
Sells (12M)
Total value (12M): $6.57M
FAVORITE ANNETTE F
Officer
$2.67M
@ $355.03 · 2026-09-15
FAVORITE ANNETTE F
Officer
$2.77M
@ $340.81 · 2026-09-08
FAVORITE ANNETTE F
Officer
$859,753
@ $305.20 · 2026-04-27
WINTERS CHAD
Officer
$269,399
@ $300.67 · 2026-04-27
WITHERSPOON CHARLES
Officer and Treasurer
$218,211
@ $310.40 · 2024-10-29
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
BAC
FearGreed
😐Neutral(53/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
WST
FearGreed
😏Greed(67/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
BAC
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (53)
WST
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (67)
View BAC Full AnalysisView WST Full Analysis

Frequently Asked Questions: BAC vs WST

Is Bank of America Corporation or West Pharmaceutical Services, Inc. more undervalued in 2026?

Based on our discounted cash flow model, BAC trades at a 59.4% margin of safety (intrinsic value $142 vs. price $58), compared to WST's -95.6% margin of safety (intrinsic $187 vs. $367).

Which stock has a wider economic moat, Bank of America Corporation or West Pharmaceutical Services, Inc.?

BAC scores 100/100 (Wide moat), while WST scores 68/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Bank of America Corporation in financial distress?

BAC's Altman Z-Score of 0.2 places it in the Distress zone, signaling elevated bankruptcy risk. WST scores 13.9 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, Bank of America Corporation or West Pharmaceutical Services, Inc.?

WST earns 17.9% ROIC versus BAC's 4.4%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Bank of America Corporation's or West Pharmaceutical Services, Inc.'s?

WST's dividend earns a safety score of 94/100 (Very Safe), compared to BAC's 79/100 (Safe). WST has raised its dividend for 3 consecutive years.